The Nomination and Remuneration Committee at its meeting held on August 13, 2025 has considered and approved the allotment of 42,050 equity shares of face value of Rs. 5/- each pursuant to the exercise of the stock options by the eligible employees of the Company under the Genesys ESOP Scheme -2020 and Genesys ESOP Scheme -2022.
GENESYS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
The Nomination and Remuneration Committee of Genesys International Corporation approved the allotment of 42,050 equity shares of face value Rs. 5 each on August 13, 2025. These shares were issued to eligible employees who exercised their stock options under the Genesys ESOP Scheme 2020 and ESOP Scheme 2022. Post-allotment, the company's paid-up equity capital increased to Rs. 20.86 crore, divided into 4,17,18,912 equity shares. The newly issued shares will carry equal rights as existing equity shares.
This is a routine ESOP allotment with minimal dilution of about 0.1% to existing shareholders. No material impact on share price is expected as the quantum of shares is very small relative to total outstanding shares.